Articles Referencing TRT

Wider Loss at Auxilium, Acquires Actient - Analyst Blog

4/30/2013, 1:46 pm from Zacks.com in Investing, Business, Stocks

Auxilium Pharmaceuticals, Inc. ( AUXL ) reported a loss of 12 cents per share in the first quarter of 2013, wider than the year-ago loss of 4 cents and the Zacks Consensus Estimate... Read >>

Positive Data on Repros' Androxal - Analyst Blog

4/4/2013, 5:09 pm from Zacks.com in Investing, Business, Stocks

Repros Therapeutics Inc. ( RPRX ) recently provided top-line results from the ZA-301 study on its late-stage candidate, Androxal, which is being evaluated for the treatment of secondary... Read >>

Auxilium Beats on All Fronts - Analyst Blog

3/1/2013, 9:10 am from Zacks.com in Investing, Business, Stocks

Auxilium Pharmaceuticals, Inc. ( AUXL ) reported fourth-quarter 2012 earnings per share of $1.83, well above the year-ago loss of 25 cents and the Zacks Consensus Estimate of $1.71 per... Read >>

Patent Challenge for Auxilium Pharma - Analyst Blog

1/4/2013, 6:17 pm from Zacks.com in Investing, Business, Stocks

Auxilium Pharmaceuticals, Inc. ( AUXL ) and Xstelos Holdings, Inc. ( XTLS ) recently received a notice from Upsher-Smith Laboratories, Inc. regarding the filing of  a 505(b)(2) new... Read >>